• Home
• triple d breast
• USA researchers identify potential biomarkers for detection and treatment of triple-negative breast cancer

USA researchers identify potential biomarkers for detection and treatment of triple-negative breast cancer

4.6 (281) · $ 18.00 · In stock

“The broader vision and mission of our study is to develop a minimally invasive blood test kit for early diagnostics, monitoring, and guiding therapeutic planning of triple-negative breast cancer patients.”

Triple-Negative Breast Cancer: New Treatments Are Changing Outcomes

Med School Watercooler: 2023

Immune-related biomarkers in triple-negative breast cancer

7 Recommendations for Future Research

Frontiers Potential Predictive and Prognostic Value of

USA Health scores four Nappies in local contest

Frontiers A Machine Learning Model to Predict the Triple

Frontiers Triple-Negative Breast Cancer: A Brief Review About

Ajay P. Singh, Ph.D.

Frontiers Gene expression profile analysis to discover molecular

Noninvasive Biomarkers: Emerging Trends in Early Detection of

Med School Watercooler: 2023

Frontiers Potential utility of miRNAs for liquid biopsy in

Machine learning analysis identifies genes differentiating triple